Pharmaceutical Science & Innovation | FD Zhangjiang: innovative Pharmaceutical Enterprises with Photodynamic Therapy and Anti-tumor characteristics
The company has four core platforms: genetic engineering technology, photodynamic drug technology, nanotechnology and oral solid preparation technology, for the development of new antibody coupling drugs (ADC), photodynamic drugs, improved preparations, small molecular drugs and so on. The reserve of the research pipeline is rich, and a number of innovative molecules or new indications are in the clinical research stage, covering tumors, skin, autoimmune diseases and other fields, with the continuous progress of clinical progress, laying the foundation for long-term growth.
Source: The above information is fromGuotai Junan Securities, with source link: www.gtja.com. Please contact this company if full report is needed.